NCT03609333View on ClinicalTrials.gov

Characterizing the cerebrovAscular Physiology of Optimal Mean Arterial Pressure Targeted Resuscitation

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 12, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Cardiac Arrest
Interventions
DEVICE

Multimodal Neuromonitoring

Application of multimodal neuromonitoring

Trial Locations (1)

V5Z 1M9

Vancouver General Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT03609333 - Characterizing the cerebrovAscular Physiology of Optimal Mean Arterial Pressure Targeted Resuscitation | Biotech Hunter | Biotech Hunter